The Impact of IL2ra Induction Therapy in Kidney Transplantation Using Tacrolimus- and Mycophenolate-Based Immunosuppression
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Transplantation
Reference19 articles.
1. Immunosuppression: Evolution in practice and trends, 1994–2004.;Meier-Kriesche;Am J Transplant,2006
2. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.;Brennan;N Engl J Med,2006
3. Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.;Nashan;Transplantation,1999
4. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.;Vincenti;N Engl J Med,1998
5. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.;Kahan;Transplantation,1999
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of Crush Syndrome Patients With and Without Acute Kidney Injury during the 2023 Kahramanmaraş Earthquake: Experience of a Tertiary Referral Center from Türkiye;Turkish Journal of Nephrology;2024-04-09
2. Current Induction Therapy Strategies and Anti-T Lymphocyte Globulin Usage in Kidney Transplantation: Consensus-Based Recommendations by a Turkish Expert Panel;Turkish Journal of Nephrology;2024-04-09
3. Role of Induction in a Haplomatch, Related, Low-risk, Living-donor Kidney Transplantation with Triple Drug Immunosuppression: A Single-center Study;Indian Journal of Nephrology;2023-08-10
4. Outcomes of abo-incompatible kidney transplantation: Novel ways of reducing rejection, complications, and cost;Transplantation Reports;2023-06
5. The impact of induction therapy in low-immunological risk kidney transplant recipients regardless of HLA matching;Transplant Immunology;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3